Literature DB >> 26087995

Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.

S Mine1, Y Kurokawa2, H Takeuchi3, K Kishi4, Y Ito5, M Ohi6, T Matsuda3, T Hamakawa2, S Hasegawa7, T Yoshikawa8, N Hiki9.   

Abstract

BACKGROUND: The optimal surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction (AEG) has not yet been agreed. Here we investigated whether the distance from the esophagogastric junction (EGJ) to the distal end of the tumor was related to the distribution of involved abdominal lymph nodes in Siewert type II tumors.
METHODS: A total of 288 patients with pT2-4 AEG Siewert II, treated by R0 surgical resection at 7 institutions in Japan, were retrospectively investigated. The distribution of involved abdominal nodes was correlated with the distance from the EGJ to the distal end of the tumor.
RESULTS: In patients where the distance from the EGJ to the distal end of the tumor was ≤30 mm, the frequency of nodal involvement along the greater curvature or antrum was low (2.2%). In contrast, in patients where the distance was >50 mm, the incidence of this nodal involvement was 20.0%. In patients where the distance was 30-50 mm incidence was intermediate (8.0%). Multivariate analyses showed that the distance from the EGJ to the distal end of the tumor was significantly related to lymph node involvement along the greater curvature or antrum (odds ratio 3.7, 95% confidence interval 1.3-11, p = 0.006).
CONCLUSIONS: When the distance from the EGJ to the distal end of the tumor is ≤ 30 mm for Siewert II AEG, esophagectomy or proximal gastrectomy is sufficient from the point of view of abdominal lymphadenectomy. However, a total gastrectomy should be considered for abdominal lymphadenectomy when this distance is > 50 mm.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Esophagectomy; Esophagogastric junction; Gastrectomy; Lymphadenectomy

Mesh:

Year:  2015        PMID: 26087995     DOI: 10.1016/j.ejso.2015.05.004

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  14 in total

1.  Prediction of mediastinal lymph node metastasis in adenocarcinoma of the esophagogastric junction.

Authors:  Henrik Nienhüser; Thomas Schmidt
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

2.  Prognostic Significance of Hiatal Hernia in Patients with Gastric Cancer Located within the Upper-Third of the Stomach.

Authors:  Suguru Maruyama; Yoshihiko Kawaguchi; Hidenori Akaike; Kensuke Shiraishi; Ryo Saito; Hiroki Shimizu; Shinji Furuya; Naohiro Hosomura; Hidetake Amemiya; Hiromichi Kawaida; Makoto Sudo; Shingo Inoue; Hiroshi Kono; Daisuke Ichikawa
Journal:  World J Surg       Date:  2020-03       Impact factor: 3.352

3.  Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.

Authors:  Shizuki Sugita; Takahiro Kinoshita; Akio Kaito; Masahiro Watanabe; Hideki Sunagawa
Journal:  Surg Endosc       Date:  2017-06-27       Impact factor: 4.584

4.  Side-overlap esophagogastric tube (SO-EG) reconstruction after minimally invasive Ivor Lewis esophagectomy or laparoscopic proximal gastrectomy for cancer of the esophagogastric junction.

Authors:  Hisahiro Hosogi; Masazumi Sakaguchi; Daisuke Yagi; Ryohei Onishi; Yasuhiro Hashimoto; Yoshiharu Sakai; Seiichiro Kanaya
Journal:  Langenbecks Arch Surg       Date:  2021-11-13       Impact factor: 3.445

5.  Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China.

Authors:  Baoyu Zhao; Zhenzhan Zhang; Debin Mo; Yiming Lu; Yanfeng Hu; Jiang Yu; Hao Liu; Guoxin Li
Journal:  Front Oncol       Date:  2019-01-21       Impact factor: 6.244

Review 6.  Current surgical treatment of esophagogastric junction adenocarcinoma.

Authors:  Shun Zhang; Hajime Orita; Tetsu Fukunaga
Journal:  World J Gastrointest Oncol       Date:  2019-08-15

Review 7.  Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.

Authors:  Jin-On Jung; Henrik Nienhüser; Nikolai Schleussner; Thomas Schmidt
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

8.  Current status of lymph node dissection in gastric cancer.

Authors:  Bin Ke; Han Liang
Journal:  Chin J Cancer Res       Date:  2021-04-30       Impact factor: 5.087

Review 9.  Surgical Treatment of Gastroesophageal Junction Cancer.

Authors:  Tadayoshi Hashimoto; Yukinori Kurokawa; Masaki Mori; Yuichiro Doki
Journal:  J Gastric Cancer       Date:  2018-09-07       Impact factor: 3.720

10.  Can proximal Gastrectomy Be Justified for Advanced Adenocarcinoma of the Esophagogastric Junction?

Authors:  Yuya Sato; Hitoshi Katai; Maiko Ito; Masahiro Yura; Sho Otsuki; Yukinori Yamagata; Shinji Morita
Journal:  J Gastric Cancer       Date:  2018-11-08       Impact factor: 3.720

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.